Finance

Lists
Why is VERA down २.३७%?
Dive Deeper
VERA:NASDAQ
Vera Therapeutics, Inc
US$ २५.५८
-२.३७%
(-०.६२) 1D
US$ २५.५८
०.००% (०.००)
After hours
Closed: नोभेम्बर १८, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VERA...
Open
US$ २६.११
High
US$ २६.५४
Low
US$ २५.३४
Mkt. cap
१.८५ अरब
Avg. vol.
१५.९५ लाख
Volume
९.५१ लाख
52-wk high
US$ ५६.०४
52-wk low
US$ २५.३४
EPS
-US$ ५.९०
Beta
१.०७
Shares outstanding
७.२३ करोड
No. of employees
३६२
Open
US$ २६.११
High
US$ २६.५४
Low
US$ २५.३४
Mkt. cap
१.८५ अरब
Avg. vol.
१५.९५ लाख
Volume
९.५१ लाख
52-wk high
US$ ५६.०४
52-wk low
US$ २५.३४
EPS
-US$ ५.९०
Beta
१.०७
Shares outstanding
७.२३ करोड
No. of employees
३६२
News stories
From web sources and news partners
FXStreet
FXStreet
·
५ घण्टा पहिले
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
BigGo Finance
BigGo Finance
·
८ घण्टा पहिले
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
Traders Union
Traders Union
·
१ घण्टा पहिले
S&P 500 dips below 200-day average after long streak, Ryan Detrick notes
About Vera Therapeutics, Inc
CEO-
Employees३६२
Founded२०१६
HeadquartersBrisbane, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websiteveratx.com
Analyst ratings
Based on 13 analysts giving stock ratings to VERA in the past 3 months
Strong buy
Buy
11
Hold
2
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for VERA in the last 3 months.
Highest
Current US$ २५.५८
US$ १००.०० (+२९०.९३%)
Average
US$ ६८.८२ (+१६९.०४%)
Lowest
US$ २९.०० (+१३.३७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Leerink Partners
Hold
Maintained
US$ ३५.००
+३६.८%
11/17/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
US$ ७५.००
+१९३.२%
11/12/2026
Dina Ramadane
Bank of America Securities
Buy
Maintained
-
-
11/06/2026
Laura Chico
Wedbush
Hold
Maintained
US$ २९.००
+१३.४%
11/06/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Maintained
US$ १००.००
+२९०.९%
11/05/2026
Vamil Divan
Guggenheim
Buy
Reiterated
US$ ६६.००
+१५८%
11/05/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
US$ ७५.००
+१९३.२%
11/06/2026
Will Soghikian
Leerink Partners
Hold
Maintained
US$ ३४.००
+३२.९%
10/27/2026
Paul Choi
Goldman Sachs
Buy
Reiterated
US$ ८०.००
+२१२.७%
10/22/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
US$ ७०.००
+१७३.७%
10/15/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ ५९.००
+१३०.६%
09/16/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
US$ ९०.००
+२५१.८%
09/15/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
09/15/2026
Ritu Baral
TD Cowen
Buy
Maintained
US$ ७८.००
+२०४.९%
08/31/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
US$ ९१.००
+२५५.७%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
US$ ७०.००
+१७३.७%
06/11/2026
Andy Chen
Wolfe Research
Buy
Maintained
US$ ८८.००
+२४४%
06/02/2026
Unknown Analyst
Wedbush
Hold
Maintained
US$ ३५.००
+३६.८%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
-
-
-
१.०३ करोड
Cost of goods sold
-
-
-
३२.९६ लाख
Cost of revenue
-
-
-
३२.९६ लाख
Research and development expenses
५.९३ करोड
८.६० करोड
६.०१ करोड
४.१३ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.४९ करोड
३.९१ करोड
५.२४ करोड
६.१४ करोड
Operating expense
९.४२ करोड
१२.५१ करोड
११.२५ करोड
१०.२७ करोड
Total operating expenses
९.४२ करोड
१२.५१ करोड
११.२५ करोड
१०.६० करोड
Operating income
-९.४२ करोड
-१२.५१ करोड
-११.२५ करोड
-९.५७ करोड
Other non operating income
-३.०३ लाख
-३२.०० हजार
-४.८३ लाख
-४.७२ लाख
EBT including unusual items
-९.११ करोड
-१२.१० करोड
-१०.९५ करोड
-९.३७ करोड
EBT excluding unusual items
-९.०९ करोड
-१२.०६ करोड
-१०.९५ करोड
-९.३७ करोड
Income tax expense
१.०० हजार
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-९.११ करोड
-१२.१० करोड
-१०.९५ करोड
-९.३७ करोड
Net profit margin
-
-
-
-९११.८५%
Earnings per share
-१.३९
-१.६९
-१.५२
-१.३०
Interest and investment income
५५.१७ लाख
६३.५५ लाख
५३.४८ लाख
४३.३६ लाख
Interest expense
-१९.०४ लाख
-१८.२३ लाख
-१८.४८ लाख
-१८.७३ लाख
Net interest expenses
३६.१३ लाख
४५.३२ लाख
३५.०० लाख
२४.६३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-९.४१ करोड
-१२.५० करोड
-११.२४ करोड
-९.४९ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू